|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.900 GBX | -8.14% |
|
+20.43% | +97.50% |
| 26/05 | EARNINGS & TRADING: MP Evans restarts buybacks with new programme | AN |
| 26/05 | Poolbeg Pharma Reports Positive Meeting With US FDA for Cytokine Release Syndrome Therapy | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 8.6 | 8.6 | 8.6 |
| Spread/Res. | -8.14% | -8.14% | -8.14% |
| Spread/Supp. | +42.34% | +42.34% | +88.10% |
| Support | 5.55 | 5.55 | 4.2 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- POLB Stock
- Charts Poolbeg Pharma PLC
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition